Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer

Cancer Medicine

Volumn 6, Issue 5, 2017, Pages 994-1001

  Zhao, Wei ^a,b   Ding, Guipeng ^a   Wen, Jinbo ^a   Tang, Qi ^a   Yong, Hongmei ^c   Zhu, Huijun ^b   Zhang, Shu ^b   Qiu, Zhenning ^a   Feng, Zhenqing ^a   Zhu, Jin ^a,d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

^d Huadong Medical Institute of Biotechniques   (China)

Author keywords

AREG; coexpression; correlation; gastric cancer; Trop2

Indexed keywords

AMPHIREGULIN; BIOLOGICAL MARKER; MEMBRANE PROTEIN; PROTEIN TROP2; UNCLASSIFIED DRUG; AREG PROTEIN, HUMAN; CELL ADHESION MOLECULE; TACSTD2 PROTEIN, HUMAN; TUMOR ANTIGEN;

ADULT; AREG GENE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE MARKER; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TROP2 GENE; TUMOR VOLUME; AGED; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; SURVIVAL ANALYSIS; UPREGULATION;

ADULT; AGED; AMPHIREGULIN; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 85014161313     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.1018     Document Type: Article

References (30)

1. Du, M., W. Wang, H. Jin, Q. Wang, Y. Ge, J. Lu, et al. 2015. The association analysis of lncRNA HOTAIR genetic variants and gastric cancer risk in a Chinese population. Oncotarget 6:31255–31262.
2. Liu, L., Q. Chen, R. Lai, X. Wu, X. Wu, F. Liu, et al. 2010. Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer. J Biomed Res 24:187–197.
3. Sun, R., X. Wang, H. Zhu, H. Mei, W. Wang, S. Zhang, et al. 2014. Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues. Oncotarget 5:12398–12409.
4. Yoon, H., and N. Kim. 2015. Diagnosis and management of high risk group for gastric cancer. Gut. Liv. 9:5–17.
5. Shvartsur, A., and B. Bonavida. 2015. Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications. Genes Cancer 6:84–105.
6. Cubas, R., M. Li, C. Chen, and Q. Yao. 2009. Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim. Biophys. Acta 1796:309–314.
7. Lin, J. C., Y. Y. Wu, J. Y. Wu, T. C. Lin, C. T. Wu, Y. L. Chang, et al. 2012. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO Mol. Med. 4:472–485.
8. Wanger, T. M., S. Dewitt, A. Collins, N. J. Maitland, Z. Poghosyan, and V. Knauper. 2015. Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17. Cell. Signal. 27:1325–1335.
9. Wang, J., K. Zhang, D. Grabowska, A. Li, Y. Dong, R. Day, et al. 2011. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma. Mol. Cancer Res. 9:1686–1695.
10. Li, M. L., J. C. Zhang, S. G. Li, W. G. Wu, L. H. Rao, P. Dong, et al. 2012. Characteristic gene expression profiles in the progression from normal gastric epithelial cells to moderate gastric epithelial dysplasia and to gastric cancer. Chin Med J (Engl) 125:1777–1783.
11. Kneissl, J., S. Keller, T. Lorber, S. Heindl, G. Keller, I. Drexler, et al. 2012. Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines. Int. J. Oncol. 41:733–744.
12. Katoh, Y., and M. Katoh. 2006. Canonical WNT signaling pathway and human AREG. Int. J. Mol. Med. 17:1163–1166.
13. Yoshida, M., T. Shimura, S. Fukuda, T. Mizoshita, S. Tanida, H. Katoka, et al. 2012. Nuclear translocation of pro-amphiregulin induces chemoresistance in gastric cancer. Cancer Sci. 103:708–715.
14. Roskoski, R. Jr. 2014. The ErbB/HER family of protein-tyrosine kinases and cancer. Pharmacol. Res. 79:34–74.
15. Eckstein, N., K. Servan, L. Girard, D. Cai, G. von Jonquieres, U. Jaehde, et al. 2008. Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 283:739–750.
16. Edgar, K. A., L. Crocker, E. Cheng, M. C. Wagle, M. Wongchenko, Y. Yan, et al. 2014. Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibition. Genes Cancer 5:113–126.
17. Zhao, W., H. Zhu, S. Zhang, H. Yong, W. Wang, Y. Zhou, et al. 2016. Trop2 is overexpressed in gastric cancer and predicts poor prognosis. Oncotarget 7:6136–6145.
18. Chen, F., X. Zhuang, L. Lin, P. Yu, Y. Wang, Y. Shi, et al. 2015. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. 13:45.
19. Sunakawa, Y., and H. J. Lenz. 2015. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network. Curr. Treat. Options Oncol. 16:17.
20. Qiu, X., Y. You, J. Huang, X. Wang, H. Zhu, and Z. Wang. 2015. LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma. Int J Clin Exp Pathol 8:5519–5527.
21. Zhai, X., H. Zhu, W. Wang, S. Zhang, Y. Zhang, and G. Mao. 2014. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. Med. Oncol. 31:970.
22. Sue, S., W. Shibata, and S. Maeda. 2015. Helicobacter pylori-Induced Signaling Pathways Contribute to Intestinal Metaplasia and Gastric Carcinogenesis. Biomed Res Int 2015:737621.
23. Chen, M. B., H. F. Wu, Y. Zhan, X. L. Fu, A. K. Wang, L. S. Wang, et al. 2014. Prognostic value of TROP2 expression in patients with gallbladder cancer. Tumour Biol. 35:11565–11569.
24. Liu, T., Y. Liu, X. Bao, J. Tian, Y. Liu, and X Yang. 2013. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PLoS ONE 8:e75864.
25. Wu, H., H. Xu, S. Zhang, X. Wang, H. Zhu, H. Zhang, et al. 2013. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma. Head Neck 35:1373–1378.
26. Fong, D., G. Spizzo, J. M. Gostner, G. Gastl, P. Moser, C. Krammel, et al. 2008. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod. Pathol. 21:186–191.
27. Lin, H., H. Zhang, J. Wang, M. Lu, F. Zheng, C. Wang, et al. 2014. A novel human Fab antibody for Trop2 inhibits breast cancer growth in vitro and in vivo. Int. J. Cancer 134:1239–1249.
28. Guerra, E., M. Trerotola, R. Dell’ Arciprete, V. Bonasera, B. Palombo, T. EI-Sewedy, et al. 2008. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res. 68:8113–8121.
29. Ichikawa, W., M. Terashima, A. Ochiai, K. Kitada, I. Kurahashi, S. Sakuramoto, et al. 2016. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer. Gastric Cancer. doi:10.1007/s10120-016-0600-x.
30. Sunakawa, Y., D. Yang, M. Moran, S. H. Astrow, A. Tsuji, C. Stephens, et al. 2016. Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer. Cancer Biol. Ther. 17:751–759.